CD19-targeting fusion protein combined with PD1 antibody enhances anti-tumor immunity in mouse models-Reference-Cited by-同舟云学术

CD19-targeting fusion protein combined with PD1 antibody enhances anti-tumor immunity in mouse models

Published:2020-01-01 Issue:1 Volume:9 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Lv Zhuangwei¹²,Zhang Ping¹²,Li Dandan¹²,Qin Mengting¹²,Nie Longzhu³,Wang Xiaoqian⁴,Ai Li¹,Feng Zhaozu³,Odhiambo Woodvine Otieno¹,Ma Yunfeng¹²,Ji Yanhong¹²⁵

Affiliation:

1. Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Center, Xi’an, China

2. Institute of Infection and Immunity, Xi’an Jiaotong University Translational Medicine Center, Xi’an, China

3. School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Center, Xi’an, China

4. The Clinical Laboratory, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

5. Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education of China, Xi’an Jiaotong University, Xi'an, P. R. China

Funder

China Postdoctoral Science Foundation

National Natural Science Foundation of China

Natural Science Foundation of Shaanxi Province

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2020.1747688

Reference51 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Checkpoint Blockade Strategies in the Treatment of Breast Cancer: Where We Are and Where We Are Heading

3. HER2 as an Emerging Oncotarget for Colorectal Cancer Treatment After Failure of Anti-Epidermal Growth Factor Receptor Therapy

4. Immunosuppressive Strategies that are Mediated by Tumor Cells

5. Immune surveillance by the liver

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast cancer immunotherapy using scFv antibody-based approaches, a systematic review;Human Immunology;2024-09

2. Development of an immunoinflammatory indicator-related dynamic nomogram based on machine learning for the prediction of intravenous immunoglobulin-resistant Kawasaki disease patients;International Immunopharmacology;2024-06

3. CD8+ T cell-based cancer immunotherapy;Journal of Translational Medicine;2024-04-29

4. Unlocking PD‐1 antibody resistance: The MUC1 DNA vaccine augments CD8⁺ T cell infiltration and attenuates tumour suppression;Scandinavian Journal of Immunology;2024-01-19

5. Therapeutic Fusion Proteins;The AAPS Journal;2023-11-30